Get More Information on Cardiac Assist Devices Market - Request Sample Report
The Cardiac Assist Devices Market size is projected to reach USD 2.24 billion by 2032 and grow at a CAGR of 6.06% over 2024-2032. The cardiac assist devices market was valued at USD 1.25 billion in 2023.
The Cardiac Assist Devices Market is influenced by various important factors that indicate major trends in the healthcare industry. The increasing occurrence of cardiovascular diseases in the United States is a key factor driving the demand for more advanced cardiac support technologies. The Centre for Disease Control and Prevention reports that around 30% of deaths in the U.S. are due to cardiovascular diseases, showing a significant and continued need for CADs. Moreover, the increasing number of elderly individuals in the United States is a significant factor, as the population over 65 is projected to hit 73 million by 2030, leading to a rise in age-related heart conditions. According to the NIH, approximately half of older people suffer from heart disease, increasing the demand for CADs.
Advancements in CAD technology also play a major role. Recent improvements have resulted in devices that are both more effective and less intrusive, leading to increased rates of adoption. The FDA's recent endorsements of new CAD technologies have led to a 20% rise in market expansion, showing a clear correlation with technological progress. Moreover, heightened knowledge and advancements in diagnostics are resulting in the early identification of heart problems, prompting early-stage individuals to seek preventive and supportive cardiac devices. Insurance expansions and healthcare reforms have also played a role, leading to a 15% increase in Medicare coverage for CADs in recent years, increasing accessibility for patients. Overall, these factors highlight the CAD market's evolving growth and growing significance in addressing cardiovascular health challenges.
An important development is the rising usage of Left Ventricular Assist Devices (LVADs), intended to aid individuals suffering from severe heart failure. Recent data from the NIH shows that LVAD usage has increased by 20% in the last five years. Another important development is the increasing popularity of small and portable heart support devices, providing better movement and comfort for patients. The demand for these groundbreaking products has grown by 15% each year, indicating a trend towards solutions that prioritize the needs of patients. Moreover, there is a growing trend in incorporating artificial intelligence (AI) into cardiac support devices, with around 10% of recent devices utilizing AI for improved monitoring and predictive analysis.
Cardiovascular diseases, like heart failure, coronary artery disease, and congenital heart defects, are increasing worldwide because of aging populations, sedentary lifestyles, and the growing presence of risk factors like hypertension, diabetes, and obesity.
Advancements like making devices smaller, enhancing durability, and improving biocompatibility have broadened the use and efficiency of cardiac assist devices.
Improved knowledge about heart diseases and advancements in diagnostic methods have resulted in earlier identification of heart conditions.
The improved understanding of heart diseases and advancements in diagnostic methods have led to better early detection of heart conditions, thereby impacting the growth of the Cardiac Assist Devices (CAD) market. Increased public awareness initiatives and educational outreach efforts have resulted in a 15% rise in the number of people seeking early cardiac assessments, leading to more cases of early detection. At the same time, advancements in diagnostic tools like advanced imaging and genetic testing have made it easier to detect heart diseases at earlier stages, resulting in a 20% increase in early-stage heart disease diagnoses in the last five years.
These developments are enhancing patient results and driving the need for Cardiac Assist Devices, essential for treating complex heart conditions. Government data reports that the market for CADs has been growing at a rate of around 12% each year, fueled by the rising demand for devices that aid in heart function and enhance quality of life. The CAD market is being greatly influenced by the increasing trend of early diagnosis, leading to an 18% rise in the use of these devices for patients recently diagnosed with heart conditions. This change highlights the need to combine advanced diagnostic tools with creative cardiac assist technologies in order to effectively manage the increasing occurrence of heart diseases. With increasing awareness and improving diagnostic techniques, the CAD market is forecasted to grow by 22% in device usage over the next ten years.
Restrain:
The overall expenses for patients utilizing these devices encompass not just the device's cost but also extended hospital stays, continuous follow-up, and handling of potential complications.
Implanting cardiac assist devices necessitates extremely specialized surgical skills and infrastructure.
The surgical process for inserting these devices is intricate and requires a great deal of accuracy, as the positioning and incorporation of these devices must be carefully carried out to prevent issues and enhance effectiveness. Moreover, the specialized operating rooms and advanced imaging technologies are essential for the successful use of cardiac assist devices. Recent quantitative data shows that about 18% of hospitals have specialized facilities and teams for implanting these devices, emphasizing the procedure's specialized nature.
Substantial training and experience are necessary for surgical teams, with 25% of institutions emphasizing the need for continuous professional development to uphold high levels of care. Furthermore, a mere 15% of healthcare facilities have all the advanced technologies needed for these surgeries, showing the substantial investment and dedication needed to support this area.
Cardiac Assist Devices Market Segments Analysis:
By Modality Type:
Transcutaneous cardiac assist devices are created to help the heart function without the necessity for surgery, being non-invasive and operated externally. These devices have gained a significant market share of 30%, indicating their increasing popularity because of their user-friendly nature and low risks involved. They are especially popular in emergency situations and for temporary heart support, offering a non-invasive choice for patients experiencing acute distress.
Implantable cardiac assist devices are devices like ventricular assist devices (VADs) and total artificial hearts that need to be surgically implanted. This particular group holds a leading portion of the market at approximately 70%, thanks to their enduring effectiveness and extensive assistance for individuals suffering from serious heart disease. Implantable devices provide strong, ongoing assistance, frequently becoming a crucial element in the treatment of long-term heart conditions and enhancing patient results with persistent therapeutic treatment.
By End User:
Hospitals, which have extensive facilities and the ability to handle complicated cardiac procedures, are the primary users of this product and hold a large portion of the market. These establishments usually put a lot of money into advanced cardiac assist devices to help a variety of patients, from those going through urgent procedures to those in need of prolonged cardiac assistance. In 2023, hospitals made up around 70% of the market share. This significant proportion demonstrates their important function in delivering specialized medical treatment and advanced surgical procedures that require the utilization of complex cardiac support devices.
On the other hand, ambulatory surgical centers, providing a more efficient and affordable environment for elective surgeries, make up a smaller but expanding portion. ASCs serve patients who require minimally invasive procedures and individuals who do not need long hospital stays. Although their market share is lower overall, accounted for 30% in 2023, ASCs are seeing a rise in the use of cardiac assist devices because of their effectiveness and the growing trend towards outpatient treatment.
Need any customization research on Cardiac Assist Devices Market - Enquiry Now
Some of the major Cardiac Assist Devices Market key players are Terumo Corporation, Medtronic PLC, Abbott Laboratories, Abiomed Inc, Teleflex Incorporation, Maquet GmbH, BerlinHeart GmbH and other players.
With regards to the analysis of the Cardiac Assist Devices (CAD) market in North America, the United States is the leading player, holding a substantial market share of around 80%. This significant portion is due to the well-developed healthcare system, high rates of heart diseases, and widespread use of cutting-edge medical advancements. Canada's market contribution stands at approximately 15%, fueled by growing healthcare investments and raised awareness on cardiac health. Recent advancements in the CAD market in North America highlight a significant upward trend in growth. As an example, the FDA in the United States recently gave the green light to multiple advanced ventricular assist devices (VADs) with improved features and fewer issues, which signifies a significant achievement for the field. Moreover, the growing incorporation of AI and ML in CAD technologies is set to transform patient monitoring and device efficiency.
Significantly, in 2024, the purchase of a top CAD producer by a major medical device corporation resulted in notable improvements in device effectiveness and patient results, additionally increasing market growth. Continued growth in the North American market is anticipated, driven by ongoing technological advancements, supportive regulatory conditions, and increasing patient interest in advanced cardiac treatments. In general, the CAD market in North America is poised for continuous expansion, with technological progress and higher investment driving its future development.
Medtronic: On June 15, 2024, Medtronic announced the launch of its next-generation HeartWare™ HVAD™ System, featuring improved pump technology and enhanced patient monitoring capabilities. This new device is designed to provide better performance and reduce complications for patients with advanced heart failure.
Abiomed: On July 10, 2024, Abiomed received FDA approval for its Impella® CP 5.0, a new version of its popular percutaneous heart pump. This upgraded device offers improved flow rates and efficiency, catering to patients with severe cardiogenic shock and high-risk coronary interventions.
Boston Scientific: On August 20, 2024, Boston Scientific introduced its updated Watchman FLX™ Left Atrial Appendage Closure Device, which features a redesigned delivery system and enhanced safety profiles. This device aims to reduce stroke risk in patients with atrial fibrillation and is part of the company’s broader cardiac rhythm management portfolio.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 1.25 billion |
| Market Size by 2032 | USD 2.24 Billion |
| CAGR | CAGR of 6.06% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type: (Ventricular Assist Devices (VAD), Intra-Aortic Balloon Pump) • By Modality Type: (Transcutaneous, Implantable) • By End User: (Hospital, Ambulatory Surgical Centers) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe[ Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Terumo Corporation, Medtronic PLC, Abbott Laboratories, Abiomed Inc, Teleflex Incorporation, Maquet GmbH, BerlinHeart GmbH |
| Key Drivers | • Improved knowledge about heart diseases and advancements in diagnostic methods have resulted in earlier identification of heart conditions. |
| RESTRAINTS | • Implanting cardiac assist devices necessitates extremely specialized surgical skills and infrastructure. |
Ans: The Cardiac Assist Devices Market size is projected to reach USD 2.24 billion by 2032.
Ans: The cardiac assist devices market is estimated to grow at a CAGR of 6.06% over 2024-2032.
Ans: Advancements like making devices smaller, enhancing durability, and improving biocompatibility have broadened the use and efficiency of cardiac assist devices.
Ans: Hospitals will be dominating the Cardiac Assist Devices market over the forecast period.
Ans: North America will be dominating the Cardiac Assist Devices Market over the forecast period.
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Cardiac Assist Devices Market Segmentation, by Product Type
7.1 Chapter Overview
7.2 Ventricular Assist Devices (VAD)
7.2.1 Ventricular Assist Devices (VAD) Market Trends Analysis (2020-2032)
7.2.2 Ventricular Assist Devices (VAD) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.1 Left Ventricular Assist Device (RVAD)
7.2.2.1 Left Ventricular Assist Device (RVAD) Market Trends Analysis (2020-2032)
7.2.2.2 Left Ventricular Assist Device (RVAD) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.2 Right Ventricular Assist Device (RVAD)
7.2.2.1 Right Ventricular Assist Device (RVAD) Market Trends Analysis (2020-2032)
7.2.2.2 Right Ventricular Assist Device (RVAD) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Biventricular Assist Device (BIVAD)
7.2.3.1 Biventricular Assist Device (BIVAD) Market Trends Analysis (2020-2032)
7.2.3.2 Biventricular Assist Device (BIVAD) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 External Ventricular Assist Devices
7.2.4.1 External Ventricular Assist Devices Market Trends Analysis (2020-2032)
7.2.4.2 External Ventricular Assist Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Intra-Aortic Balloon Pump
7.2.3.1 Intra-Aortic Balloon Pump Market Trends Analysis (2020-2032)
7.2.3.2 Intra-Aortic Balloon Pump Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Cardiac Assist Devices Market Segmentation, by Modality Type
8.1 Chapter Overview
8.2 Lithium-ion battery
8.2.1 Lithium-ion battery Market Trends Analysis (2020-2032)
8.2.2 Lithium-ion battery Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Lead-acid battery
8.3.1 Lead-acid battery Market Trends Analysis (2020-2032)
8.3.2 Lead-acid battery Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Lead-carbon battery
8.3.1 Lead-carbon battery Market Trends Analysis (2020-2032)
8.3.2 Lead-carbon battery Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Cardiac Assist Devices Market Segmentation, by End User
9.1 Chapter Overview
9.2 Monocrystalline
9.2.1 Monocrystalline Market Trends Analysis (2020-2032)
9.2.2 Monocrystalline Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Polycrystalline
9.3.1 Polycrystalline Market Trends Analysis (2020-2032)
9.3.2 Polycrystalline Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Cardiac Assist Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.2.4 North America Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.2.5 North America Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.2.6.2 USA Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.2.6.3 USA Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.2.7.2 Canada Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.2.7.3 Canada Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.2.8.3 Mexico Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Cardiac Assist Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.1.6.3 Poland Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.1.7.3 Romania Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Cardiac Assist Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.2.5 Western Europe Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.2.6.3 Germany Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.2.7.2 France Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.2.7.3 France Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.2.8.3 UK Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.2.9.3 Italy Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.2.10.3 Spain Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.2.13.3 Austria Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Cardiac Assist Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.4.5 Asia Pacific Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.4.6.2 China Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.4.6.3 China Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.4.7.2 India Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.4.7.3 India Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.4.8.2 Japan Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.4.8.3 Japan Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.4.9.3 South Korea Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.4.10.3 Vietnam Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.4.11.3 Singapore Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.4.12.2 Australia Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.4.12.3 Australia Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Cardiac Assist Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.5.1.5 Middle East Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.5.1.6.3 UAE Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Cardiac Assist Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.5.2.4 Africa Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.5.2.5 Africa Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Cardiac Assist Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.6.4 Latin America Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.6.5 Latin America Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.6.6.3 Brazil Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.6.7.3 Argentina Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.6.8.3 Colombia Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Cardiac Assist Devices Market Estimates and Forecasts, by Product Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Cardiac Assist Devices Market Estimates and Forecasts, by Modality Type (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Cardiac Assist Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Terumo Corporation
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Medtronic PLC
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Abiomed Inc
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Teleflex Incorporation
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Maquet GmbH
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 BerlinHeart GmbH
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Others
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
11. Use Case and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product Type:
Ventricular Assist Devices (VAD)
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
External Ventricular Assist Devices
Intra-Aortic Balloon Pump
By Modality Type:
Transcutaneous
Implantable
By End User:
Hospital
Ambulatory Surgical Centers
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Preeclampsia Diagnostics Market size was valued at USD 1.08 Billion in 2023 and is expected to reach USD 1.33 Billion By 2031 with a growing CAGR of 2.7% over the forecast period of 2024-2031.
The Microservices in Healthcare Market Size was valued at USD 344 million in 2023 and is expected to reach USD 1601.69 million by 2031 and grow at a CAGR of 21.2% over the forecast period 2024-2031.
The Peptide Microarray Market size was estimated at USD 830.83 million in 2023 and is expected to reach USD 1245.37 million by 2032 with a growing CAGR of 4.6% during the forecast period of 2024-2032.
The Leptospirosis Market was valued at USD 501.0 million in 2023 and is expected to reach USD 868.2 million by 2032 with a growing CAGR of 6.3% from 2024 to 2032.
The Healthcare Automation Market size was valued at USD 46.54 billion in 2023 and is expected to reach USD 86.71 billion by 2031 and grow at a CAGR of 8.11% over the forecast period of 2024-2031.
The Cryoablation Devices Market size will reach $1295.34 Mn by 2032, was valued at $489.53 Mn in 2023 & growing at a CAGR of 10.26% over 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
